These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 16795042

  • 1. Inhibition of human breast cancer cell (MBA-MD-231) invasion by the Ea4-peptide of rainbow trout pro-IGF-I.
    Siri S, Chen MJ, Chen TT.
    J Cell Biochem; 2006 Dec 01; 99(5):1363-73. PubMed ID: 16795042
    [Abstract] [Full Text] [Related]

  • 2. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
    Chen MJ, Chiou PP, Lin P, Lin CM, Siri S, Peck K, Chen TT.
    J Cell Biochem; 2007 Aug 01; 101(5):1316-27. PubMed ID: 17286280
    [Abstract] [Full Text] [Related]

  • 3. Biological activity of rainbow trout Ea4-peptide of the pro-insulin-like growth factor (pro-IGF)-I on promoting attachment of breast cancer cells (MDA-MB-231) via alpha2- and beta1-integrin.
    Siri S, Chen MJ, Chen TT.
    J Cell Biochem; 2006 Dec 15; 99(6):1524-35. PubMed ID: 16817231
    [Abstract] [Full Text] [Related]

  • 4. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr 15; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 5. Tissue-type plasminogen activator is upregulated in metastatic breast cancer cells exposed to insulin-like growth factor-I.
    Chernicky CL, Yi L, Tan H, Ilan J.
    Clin Breast Cancer; 2005 Oct 15; 6(4):340-8. PubMed ID: 16277885
    [Abstract] [Full Text] [Related]

  • 6. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
    Simeone AM, Nieves-Alicea R, McMurtry VC, Colella S, Krahe R, Tari AM.
    Int J Oncol; 2007 Apr 15; 30(4):785-92. PubMed ID: 17332916
    [Abstract] [Full Text] [Related]

  • 7. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 15; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 8. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR, Tang J, Hu G, Lin Y, Mutter W, Tong C, Karumanchi SA, Russell SJ, Sukhatme VP.
    J Natl Cancer Inst; 2006 Jun 07; 98(11):756-64. PubMed ID: 16757700
    [Abstract] [Full Text] [Related]

  • 9. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V.
    Int J Mol Med; 2008 Feb 07; 21(2):251-9. PubMed ID: 18204793
    [Abstract] [Full Text] [Related]

  • 10. IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells.
    Cheng CY, Hsieh HL, Sun CC, Lin CC, Luo SF, Yang CM.
    J Cell Physiol; 2009 Apr 07; 219(1):183-93. PubMed ID: 19097143
    [Abstract] [Full Text] [Related]

  • 11. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
    Luparello C, Sirchia R, Pupello D.
    J Cell Sci; 2003 Jun 15; 116(Pt 12):2421-30. PubMed ID: 12724357
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF, Yan PJ, Shao ZM.
    Oncogene; 2009 Nov 05; 28(44):3937-48. PubMed ID: 19701247
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of human breast carcinoma cell invasiveness and urokinase plasminogen activator activity by glucose deprivation.
    Belkacemi L, Lam E, Caldwell JD, Siemens DR, Graham CH.
    Exp Cell Res; 2006 Jun 10; 312(10):1685-92. PubMed ID: 16564525
    [Abstract] [Full Text] [Related]

  • 14. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.
    Pakneshan P, Szyf M, Rabbani SA.
    Carcinogenesis; 2005 Mar 10; 26(3):557-64. PubMed ID: 15618232
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib inhibits urokinase-type plasminogen activator (uPA) production in MDA-MB-231 breast cancer cells.
    Andrews HN, Habibi G, Kucab JE, Dunn SE.
    Breast Cancer Res Treat; 2005 Nov 10; 94(1):47-52. PubMed ID: 16172791
    [Abstract] [Full Text] [Related]

  • 16. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
    Matsuzaki H, Kobayashi H, Yagyu T, Wakahara K, Kondo T, Kurita N, Sekino H, Inagaki K, Suzuki M, Kanayama N, Terao T.
    Oncol Rep; 2005 Aug 10; 14(2):449-57. PubMed ID: 16012729
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator.
    Huang HY, Jiang ZF, Li QX, Liu JY, Wang T, Zhang R, Zhao J, Xu YM, Bao W, Zhang Y, Jia LT, Yang AG.
    Cancer Invest; 2010 Aug 10; 28(7):689-97. PubMed ID: 20636107
    [Abstract] [Full Text] [Related]

  • 18. Microinjecting recombinant rainbow trout Ea4-peptide of pro-IGF-I into zebrafish embryos causes abnormal development in heart, red blood cells, and vasculature.
    Chun CZ, Chen TT.
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Feb 10; 145(1):39-44. PubMed ID: 16914384
    [Abstract] [Full Text] [Related]

  • 19. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts.
    Hilal G, Martel-Pelletier J, Pelletier JP, Duval N, Lajeunesse D.
    Arthritis Rheum; 1999 Oct 10; 42(10):2112-22. PubMed ID: 10524682
    [Abstract] [Full Text] [Related]

  • 20. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.
    Whitley BR, Palmieri D, Twerdi CD, Church FC.
    Exp Cell Res; 2004 Jun 10; 296(2):151-62. PubMed ID: 15149846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.